FIELD: pharmaceuticals.
SUBSTANCE: invention relates to insulin conjugates that contain an insulin molecule covalently bonded to at least one bi-dentate linker having two arms, each arm independently attached to a ligand comprising a saccharide and where the saccharide is fucose.
EFFECT: insulin conjugates are characterised by a pharmacokinetic (PK) and / or pharmacodynamic (PD) profile which is sensitive to systemic concentrations of the saccharide, such as glucose or α-methylmannose even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule such as Con A.
8 cl, 22 dwg, 1 tbl, 106 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE, AND USE THEREOF | 2021 |
|
RU2840147C1 |
METHOD OF PRODUCING AN ANTIBODY-DRUG CONJUGATE | 2021 |
|
RU2841377C1 |
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
PARA-AMINOBENZYL LINKERS, METHOD FOR PRODUCTION AND USE IN CONJUGATES THEREOF | 2021 |
|
RU2839675C1 |
ANTIBODY TO B7H3-EXATECAN ANALOGUE CONJUGATE AND ITS USE IN MEDICINE | 2019 |
|
RU2785664C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN MEDICINAL PREPARATIONS | 2014 |
|
RU2694254C1 |
BIARYL DERIVATIVES AS INHIBITORS OF PROTEIN-PROTEIN INTERACTION YAP/TAZ-TEAD | 2021 |
|
RU2830596C1 |
PYRAZOLO-HETEROARYL DERIVATIVE, METHOD FOR ITS PREPARATION AND MEDICAL USE | 2017 |
|
RU2748833C2 |
CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | 2013 |
|
RU2649009C2 |
FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
Authors
Dates
2018-12-27—Published
2014-10-02—Filed